ホットストック:武田しっかり、 がん治療薬「CBP501」の第2相試験開始

ホットストック:武田しっかり、 がん治療薬「CBP501」の第2相試験開始

The 8th in Tokyo Reuters Takeda Chemical Industries, Ltd. (4502. T: stock prices, news, and report) firmly :. This company announces that the second aspect examination of clinical to non-cellule lung cancer of cancer treatment “CBP501″ that advances making to the business in cooperation with the canvas company of the drug development bio-venture (Shizuoka Prefecture Numazu City) began, and is a material on the seventh. “CBP501″ is said that the progress in the cancer cell at the cell cycle is obstructed, and there is an action that promotes the cancer cell death.

Please double-click and see each code about related information on the enterprise in the article.

トラックバック&コメント

この記事のトラックバックURL:

まだトラックバック、コメントがありません。


ミケルソン、母も乳がん…欠場は長期に »
« 勝野洋長女七奈美さん29歳が肺がんで死亡